Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Slightly Bullish +25

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

📉 Intuitive Surgical shares fell -7.8% over the past month, underperforming both the Zacks S&P 500 (-3.3%) and the Medical Instruments industry (-6.4%).

🎯 Analysts are focusing on changes in future earnings projections as the primary driver of fair stock value rather than short-term news or rumors.

💰 The company expects quarterly earnings of $2.08 per share, representing a +14.9% increase from the same quarter last year.

📈 Full-year fiscal earnings consensus is projected at $10.05 (+12.5% YoY), while next-year estimates are set at $11.39 (+13.3% YoY).

📉 The Zacks Consensus estimate changed slightly over the last month, with a minor -0.2% revision for the next fiscal year.

🌐 Based on earnings estimate revisions and other factors, Intuitive Surgical currently holds a Zacks Rank of #3 (Hold).

💵 Reported revenues of $2.87 billion in the last quarter matched consensus estimates exactly but beat EPS expectations by +12.44%.

⚙️ The company has beaten EPS estimates in each of the trailing four quarters and topped revenue estimates three times during that period.

📉 Sales projections indicate +15.8% growth for the current quarter, +14.8% for the current fiscal year, and +12.2% for next fiscal year.

💰 Valuation analysis places Intuitive Surgical at a premium to peers, earning a D grade on the Zacks Value Style Score system.

🔮 A Zacks Rank #3 suggests the stock may perform in line with the broader market in the near term despite the recent price decline.

Bullish Signals
  • Intuitive Surgical is expected to post earnings of $2.08 per share for the current quarter, indicating a change of +14.9% from the year-ago quarter.
  • The consensus earnings estimate of $10.05 for the current fiscal year indicates a year-over-year change of +12.5%, signaling sustained growth prospects.
  • For the next fiscal year, the consensus earnings estimate of $11.39 indicates a change of +13.3% from what Intuitive Surgical is expected to report a year ago.
  • The consensus sales estimate of $2.61 billion for the current quarter points to a year-over-year change of +15.8%, demonstrating robust revenue growth.
  • The reported revenues of $2.87 billion in the last quarter represented a year-over-year change of +18.8%, exceeding expectations with an EPS surprise of +12.44%.
  • Intuitive Surgical has beaten consensus EPS estimates in each of the trailing four quarters, showcasing consistent outperformance.
  • The company topped consensus revenue estimates three times over the trailing four-quarter period, indicating strong fundamentals.
  • A year-over-year change of +14.8% in current fiscal year revenue and +12.2% growth in the next fiscal year further supports long-term earnings trajectory.
Risk Factors
  • Shares of Intuitive Surgical have returned -7.8% over the past month, significantly underperforming both the Zacks S&P 500 composite (-3.3%) and the Medical Instruments industry (-6.4%).
  • The stock is rated with a Zacks Rank #3 (Hold), suggesting it may perform in line with the broader market rather than outperform.
  • Intuitive Surgical is graded D on the Zacks Value Style Score, indicating that its stock is trading at a premium to its peers and is considered overvalued based on traditional and unconventional valuation metrics.
  • For the next fiscal year, the consensus earnings estimate has changed by -0.2% over the last month, signaling a slight negative revision in analyst expectations.
Full Analysis
Intuitive Surgical, Inc. (ISRG) shares have recently declined by -7.8% over the past month, underperforming both the Zacks S&P 500 composite index, which lost -3.3%, and its respective industry sector, the Medical - Instruments, which saw a decline of -6.4%. While market rumors can cause short-term volatility, the primary determinant for long-term investment decisions remains fundamental factors, specifically earnings projections. Analysts at Zacks Investment Research emphasize that shifts in sell-side earnings estimates correlate strongly with stock price movements, as these revisions influence the calculation of a company's fair value based on its future earning stream. For the current quarter, Intuitive Surgical is projected to report earnings per share (EPS) of $2.08, representing a 14.9% increase year-over-year, while consensus estimates have remained relatively stable with a +0.3% change in the last 30 days. Annual consensus estimates show continued growth, with a forecast of $10.05 EPS for the current fiscal year (a 12.5% increase) and $11.39 EPS for the next fiscal year (a 13.3% increase). Revenue forecasts align with these projections, showing a consensus sales estimate of $2.61 billion for the quarter (+15.8% year-over-year), compared to reported revenues of $2.87 billion last quarter, which beat earnings expectations by +12.44%. The company has demonstrated strong execution, beating consensus EPS estimates for four consecutive trailing quarters and topping revenue estimates three times in that period. Despite this historical outperformance, current valuation metrics suggest Intuitive Surgical trades at a premium relative to peers, reflected in a Zacks Value Style Score of D. Based on its earnings estimate revisions and other factors, the stock currently holds a Zacks Rank #3 (Hold), indicating it may be expected to perform in line with the broader market rather than significantly outperforming or underperforming in the near term.